Health Condition 1: null- Chronic Kidney Disease
Conditions
Interventions
None listed
Sponsors
Fresenius Kabi Asia Pacific Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male and female patients with age >= 18 years and regularly attending a given site 2.Patients with CKD (glomerular filtration rate (GFR) 3.Patients with life expectancy of at least 6 months 4.Patients who are willing and able to adhere to the protocol requirements
Exclusion criteria
Exclusion criteria: 1.Patients who have undergone kidney transplant 2.Patients who have a sustained sitting systolic blood pressure (BP) more than 160 mmHg or sustained sitting diastolic BP more than 110 mmHg 3.Patients with an independently co-existing life-threatening disease, such as cancer 4.Patients who have undergone previous carotid artery surgery and/or a carotid artery stenosis greater than 75% at baseline. 5.Patients with history of co-morbidities that in the investigatorâ??s opinion would interfere with the study participation and impact life expectancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical course and therapy sequences of the Chronic Kidney Disease (CKD)Timepoint: Death or day of surgery for renal transplant or lost to follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events, mortality, co-morbiditiesTimepoint: Death or day of surgery for renal transplant or lost to follow-up | — |
Countries
India, Thailand
Contacts
Public ContactUmesh Gupta
Fresenius Kabi India Pvt. Ltd.
Outcome results
None listed